{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:26:11Z","timestamp":1790180771122,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"17","funder":[{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2018R01015"],"award-info":[{"award-number":["2018R01015"]}],"id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation of China","doi-asserted-by":"publisher","award":["LY19B020008"],"award-info":[{"award-number":["LY19B020008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National Undergraduate Training Program for Innovation and Entrepreneurship of China","doi-asserted-by":"publisher","award":["202010337029"],"award-info":[{"award-number":["202010337029"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Tyrosine kinases expressed by BCR-ABL fusion genes can cause changes in\ncell proliferation, adhesion, and survival properties, which are the main causes of chronic\nmyelogenous leukemia (CML). Inhibiting the activity of BCR-ABL tyrosine kinase has\nbecome one of the effective methods for the treatment of chronic myelogenous leukemia.\nInitially, imatinib was the first small molecule of BCR-ABL tyrosine kinases inhibitors\n(TKIs) for the effective treatment of chronic myelogenous leukemia. Later, due to the\nemergence of various BCR-ABL mutations, especially T315I mutation, imatinib developed\nstrong resistance. The second-generation kinase inhibitors dasatinib and nilotinib\nwere able to overcome most of the mutation resistance but not T315I mutations. Therefore,\nin order to further overcome the problem of drug resistance, new types of KTIs such\nas flumatinib and radotinib have been developed, providing more options for clinical\ntreatment. Some new drugs have entered clinical trials. In this review, two new BCRABL\ninhibitors (flumatinib and radotinib) and five new BCR-ABL inhibitors have been\nintroduced into the clinical market in recent years. We reviewed their research status, synthesis\nmethods, and clinical applications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867328666211012093423","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T23:09:19Z","timestamp":1634339359000},"page":"3050-3078","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Research Status, Synthesis and Clinical Application of Recently\nMarketed and Clinical BCR-ABL Inhibitors"],"prefix":"10.2174","volume":"29","author":[{"given":"Xiao-Liang","family":"Xu","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang University of Technology, and Institute of Drug Development\n& Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Cao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang University of Technology, and Institute of Drug Development\n& Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang University of Technology, and Institute of Drug Development\n& Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Wu","family":"Rao","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang University of Technology, and Institute of Drug Development\n& Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211012093423","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197175\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211012093423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T16:10:46Z","timestamp":1653322246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197175\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":0,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666211012093423","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}